Opko Health Inc (NYSE:OPK) : Wednesdays money flow points at investors jumping to buy the stock on the weakness of price. $3.64 million worth of transactions were on upticks, whereas, the downticks accounted for $3.24 million worth of transactions. The net money flow was a positive $0.4 million and the uptick to downtick ratio was 1.12. The net money flow into the stock was $0.7 million. The lack of interest in trading on downticks shows that the investors dont want to sell their holdings. The upticks accounted for $0.7 million of the total block trades, indicating continued buying interest on weakness, which bodes well for the future of the stock. Opko Health Inc (NYSE:OPK) was trading at $9.25, down $0.02 during day. The stock slid -0.16% over the previous days close. For the week, the stock recorded -2.27% over the previous weeks close.
In an insider trading activity, Frost Gamma Investments Trust, CEO of Opko Health, Inc., had purchased 18,000 shares on June 22, 2016. The total value of the transaction was $171,180. The information was disclosed with the SEC in a Form 4 Filing. The information is based on open market trades at the market prices.Option exercises are not covered. Currently the company Insiders own 40.74% of Opko Health Inc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -11.66% . Institutional Investors own 19.77% of Opko Health Inc shares. During last six month period, the net percent change held by insiders has seen a change of -0.09%.
The company shares have dropped -43.09% from its 1 Year high price. On Jul 24, 2015, the shares registered one year high at $17.51 and the one year low was seen on Jan 20, 2016. The 50-Day Moving Average price is $9.81 and the 200 Day Moving Average price is recorded at $9.70. Opko Health Inc (NYSE:OPK): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $9.34 and $9.15 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $9.36. The buying momentum continued till the end and the stock did not give up its gains. It closed at $9.30, notching a gain of 0.43% for the day. The total traded volume was 2,871,479 . The stock had closed at $9.26 on the previous day.
OPKO Health, Inc. (OPKO) is a biopharmaceutical and diagnostics company. The Company is involved in developing a range of solutions to diagnose, treat and prevent various conditions, including point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and pharmaceuticals and vaccines. It operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment consists of two operating segments pharmaceutical research and development segment and pharmaceutical operations. Its diagnostics segment consists of pathology operations and point-of-care and molecular diagnostics operations. It owns pharmaceutical operations in Chile, Spain, Mexico, Israel, Uruguay and Brazil. The product pipeline includes several pharmaceutical compounds and technologies in research and development for a range of indications and conditions.